Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 9:00 PM ET

Date/Time Source News Release
05/14/2025 04:01 PM EDT GlobeNewswire Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
03/20/2025 04:01 PM EDT GlobeNewswire Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
03/04/2025 04:05 PM EST GlobeNewswire Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
02/07/2025 10:00 AM EST GlobeNewswire Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
01/29/2025 04:05 PM EST GlobeNewswire Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
01/13/2025 07:00 AM EST GlobeNewswire Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
11/12/2024 04:01 PM EST GlobeNewswire Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
11/06/2024 04:05 PM EST GlobeNewswire Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
10/29/2024 07:46 AM EDT GlobeNewswire Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
10/29/2024 07:45 AM EDT GlobeNewswire Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
Page

Additional News

As of June 7, 2025 • 9:00 PM ET

Date/Time Source News Release
06/06/2025 08:00 AM EDT SeekingAlpha Rare Stock Picks In May 2025 - From 27 Discerning Analysts
05/23/2025 12:00 PM EDT Zacks What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock
05/15/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 15th, 2025
05/15/2025 05:30 AM EDT US Earnings Reports Expected earnings - Eledon Pharmaceuticals Inc.
05/14/2025 06:02 PM EDT SeekingAlpha Eledon Pharmaceuticals GAAP EPS of -$0.08
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Eledon Pharmaceuticals Inc.
05/06/2025 01:15 PM EDT SeekingAlpha Undercovered Dozen: Gevo, Eledon, Dorian, Iridium +
05/03/2025 08:15 AM EDT SeekingAlpha Eledon: A Company With Good Early Data In Kidney Transplant Rejection And A Full Balance Sheet
03/20/2025 04:40 PM EDT SeekingAlpha Eledon Pharmaceuticals GAAP EPS of -$0.75 misses by $0.04
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.